Michael A. Metzger
Chief Executive Officer at Syndax Pharmaceuticals · 9 reported transactions in 1 company · latest trade Jul 8, 2026
Their trades
Sold | Jul 8, 2026 | Jul 8, 2026 close $24.56 → Oct 30, 2026 close $13.65. S&P 500 +1.4% over the same days. | ||
Sold | Feb 9, 2026 | Feb 9, 2026 close $21.19 → Oct 30, 2026 close $13.65. S&P 500 +8.9% over the same days. | ||
Sold | Feb 6, 2026 | Feb 6, 2026 close $21.01 → Oct 30, 2026 close $13.65. S&P 500 +9.4% over the same days. | ||
Sold | Sep 8, 2025 | Sep 8, 2025 close $16.33 → Oct 30, 2026 close $13.65. S&P 500 +16.5% over the same days. | ||
Sold | Jul 16, 2025 | Jul 16, 2025 close $9.25 → Oct 30, 2026 close $13.65. S&P 500 +21.1% over the same days. |
$784.8K
Jul 8, 2026 close $24.56 → Oct 30, 2026 close $13.65. S&P 500 +1.4% over the same days.
$360.8K
Feb 9, 2026 close $21.19 → Oct 30, 2026 close $13.65. S&P 500 +8.9% over the same days.
$152.8K
Feb 6, 2026 close $21.01 → Oct 30, 2026 close $13.65. S&P 500 +9.4% over the same days.
$2.58M
Sep 8, 2025 close $16.33 → Oct 30, 2026 close $13.65. S&P 500 +16.5% over the same days.
$70K
Jul 16, 2025 close $9.25 → Oct 30, 2026 close $13.65. S&P 500 +21.1% over the same days.